You are here: Industry Insights > mRNA

News List

CureVac provides update on Phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoV worldpharmanews
June 21, 2021
CureVac N.V., a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced results of the second interim analysis of its international pivotal Phase 2b/3 study in ...
Australia's first locally made COVID-19 mRNA vaccine candidate is set for clinical trials firstwordpharma
June 21, 2021
Victoria's acting premier James Merlino announced on Sunday his government had allocated AUD 5 million from a AUD 50 million mRNA research fund to help the Monash Institute of Pharmaceutical Sciences manufacture doses of its mRNA vaccine candidate for tri
Danaher to acquire Aldevron from EQT for $9.6bn pharmaceutical-business-review
June 18, 2021
Danaher, a science and technology company, has agreed to acquire biotech firm Aldevron from EQT Private Equity for an enterprise value of $9.bn.
U.S. government purchases additional 200 million doses of Moderna's COVID-19 vaccine worldpharmanews
June 17, 2021
Moderna announced that the U.S. government has purchased an additional 200 million doses of Moderna's COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna's pipeline.
China’s First mRNA Covid-19 Vaccine Preps to Enter Final Stage Trials, Abogen CEO Says firstwordpharma
June 17, 2021
Suzhou Abogen Biosciences’ mRNA COVID-19 vaccine is expected to start Phase III tests in overseas countries later this month, said CEO Ying Bo, Yicai Global reported.
Prof. Ernst Wagner Joins Coriolis Pharma’s Scientific Advisory Board as Expert for Nucleic Acid Therapeutics b3cnewswire
June 15, 2021
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, today announced that Prof. Dr. Ernst Wagner has joined its scientific advisory board.
CDC COVID-19 study shows mRNA vaccines reduce risk of infection by 91 percent for fully vaccinated people worldpharmanews
June 10, 2021
A new CDC study finds the mRNA COVID-19 vaccines authorized by the Food and Drug Administration (Pfizer-BioNTech and Moderna) reduce the risk of infection by 91 percent for fully vaccinated people.
EMA to assess whether COVID-19 Vaccine Moderna can be used in adolescents europeanpharmaceuticalreview
June 10, 2021
The European Medicines Agency (EMA) has begun evaluating whether to extend the use of the COVID-19 Vaccine Moderna to include adolescents aged 12 to 17.
Vaccinations More Urgent as Variant That Crippled India Shows Up in the U.S. drugs
June 10, 2021
The highly contagious coronavirus variant that brought India to its knees this spring now accounts for 6 percent of new cases in the United States, the Biden administration said Tuesday.
Moderna and Medison Pharma Partner to Commercialize Moderna's COVID-19 Vaccine Across Central Eastern Europe and Israel americanpharmaceuticalreview
June 09, 2021
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the ...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page